Ildong Holdings Co., Ltd. (KRX:000230)

Ildong Holdings Revenue

Ildong Holdings had revenue of 153.98B KRW in the quarter ending June 30, 2026, with 6.18% growth. This brings the company's total for the last twelve months to 607.65B, up 0.05% year-over-year. In the year 2025, Ildong Holdings had annual revenue of 590.89B, down -6.90%. That makes Ildong Holdings the 11,782nd largest company in the world by revenue and 560th in South Korea.

• Revenue (ttm): 607.65B
• Revenue Growth: +0.05%
• P/S Ratio: 0.11
• Revenue / Employee: 4.47B
• Employees: 136
• Market Cap: 65.66B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicines Manufacturing and Sales 565.97B 87.6%
• Landlord Business 18.81B 2.9%
• Cosmetic Surgery Medical Devices Manufacturing, Sales and Software Development 17.75B 2.7%
• Health Functionality Food 15.87B 2.5%
• E-Commerce for Pharmaceuticals 10.79B 1.7%
• Water Ionizer 9.36B 1.4%
• Advertising Agency 5.04B 0.8%
• Clinical Pharmacology Consulting 2.20B 0.3%

By Geography

Chart

• South Korea 578.93B 98.1%
• Japan 4.14B 0.7%
• Other 3.94B 0.7%
• Southeast Asia 2.87B 0.5%

Fiscal year ended Dec 31, 2025 See the full Ildong Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	590.89B	-43.76B	-6.90%
Dec 31, 2024	634.65B	-3.79B	-0.59%
Dec 31, 2023	638.45B	-37.09B	-5.49%
Dec 31, 2022	675.54B	83.17B	14.04%
Dec 31, 2021	592.37B	-4.09B	-0.69%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error